BSEM — BioStem Technologies, Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1658678 ·
Last close
$0.94
Market Cap
$17.93M
52W High
$8.40
52W Low
$0.90
ADV30
228,610
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 7,640,885 | 4,294,088 | -9,775,949 | -11,375,654 | 43,577,416 | 971,145 | 25,250,992 |
| Jun 2026 | 7,899,249 | 4,840,661 | -8,400,687 | -8,971,360 | 48,818,296 | 6,962,492 | 21,203,699 |
| Sep 2025 | 10,473,402 | 9,268,608 | 1,448,790 | 761,052 | 62,392,843 | 27,158,117 | 12,376,434 |
| Jun 2025 | 10,963,174 | 10,277,997 | 112,759 | 10,613 | — | — | — |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-2,383,165
Investing CF
$-1,167,597
Financing CF
$-135,001
CapEx
$-2,417,597
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.49
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-38,965,381
Inventory
$4,711,775
Receivables
$6,621,357
ST Investments
—
EBIT TTM
$-6,839,138
Pretax Income TTM
$-7,324,678
Interest Exp TTM
—
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$31,754,082
EBITDA
$-32,577,720
Free Cash Flow
$3,721,609
Enterprise Value
$20,332,240
Total Cash
$971,145
Total Debt
$1,165,823
Shares Out
19,178,631
Trailing EPS
$0.88
Book Value
$0.98
ROE
-118.3%
ROA
-40.8%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 301,827,302 | 31,200,641 | 31,884,321 | 140,375,727 | 99,500,195 | 40,875,532 | 24,476,653 |
| Dec 2023 | 16,685,405 | -7,778,969 | -8,482,984 | 14,560,291 | 15,904,667 | -1,344,376 | -3,498,960 |
| Dec 2022 | 6,875,202 | -4,681,548 | -7,192,949 | 3,466,433 | 7,416,385 | -4,076,396 | 303,575 |
| Dec 2021 | 4,340,839 | -1,605,706 | -1,445,383 | 2,671,515 | 8,465,622 | -5,959,398 | -109,439 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$48,818,296
Forward EPS
$0.29
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ABOS | Acumen Pharmaceuticals, Inc. | $16.64M | $0.23 | — |
| CKDXF | Opthea Ltd | $14.64M | $0.01 | — |
| ESLA | Estrella Immunopharma, Inc. | $14.42M | $0.33 | — |
| PLUR | Pluri Inc. | $14.09M | $0.98 | — |
| ZIVO | Zivo Bioscience, Inc. | $23.18M | $5.50 | — |
News headlines (Yahoo Finance, 1h cache)
BioStem (BSEM) Q3 2026 Earnings Call Transcript
2026-11-13 05:43 · Yahoo
BioStem Technologies, Inc. (BSEM) Reports Q3 Loss, Beats Revenue Estimates
2026-11-12 22:05 · Yahoo
BioStem Technologies Reports Third Quarter 2026 Financial Results; Grows Hospital Revenue for Second Consecutive Quarter as Customers Expand Use of Portfolio
2026-11-12 21:05 · Yahoo
BioStem Technologies to Host Third Quarter 2026 Financial Results Conference Call on November 12, 2026
2026-10-29 20:05 · Yahoo
BioStem Technologies’ CEO and COO Invest $1 Million in Cash Through Exercise of Stock Options
2026-10-08 11:00 · Yahoo
BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio
2026-10-01 11:00 · Yahoo
BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules
2026-09-30 12:00 · Yahoo
Terminal1, the operating system built for public companies, announced today that BioStem Technologies, Inc. (NASDAQ: BSEM) has joined the Terminal1 platform
2026-09-21 20:30 · Yahoo
BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier
2026-09-04 11:00 · Yahoo
BioStem Technologies Eyes Surgical Growth, Manufacturing Shift After BioTissue Deal
2026-08-22 01:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.